Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Calvo

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
NPJ Breast Cancer|June 27, 2017
Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohortXavier Pivot, Gilles Romieu, Pierre Fumoleau, et al.
Molecular Oncology|August 5, 2020
Towards a cancer mission in Horizon Europe: recommendationsAnton Berns, Ulrik Ringborg, Julio E Celis, et al.
Nature Communications|July 14, 2016
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancersAnthony Ferrari, Anne Vincent-Salomon, Xavier Pivot, et al.
Biomedicine Hub|February 10, 2021
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in OncologyDenis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
Nature|April 16, 2010
International network of cancer genome projects, Thomas J Hudson, Warwick Anderson, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
NPJ Breast Cancer|June 27, 2017
Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohortXavier Pivot, Gilles Romieu, Pierre Fumoleau, et al.
Molecular Oncology|August 5, 2020
Towards a cancer mission in Horizon Europe: recommendationsAnton Berns, Ulrik Ringborg, Julio E Celis, et al.
Nature Communications|July 14, 2016
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancersAnthony Ferrari, Anne Vincent-Salomon, Xavier Pivot, et al.
Biomedicine Hub|February 10, 2021
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in OncologyDenis Horgan, Gennaro Ciliberto, Pierfranco Conte, et al.
Nature|April 16, 2010
International network of cancer genome projects, Thomas J Hudson, Warwick Anderson, et al.
Pageof 9